---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-006421"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T04:42:48.799765+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics reports record 2023 revenue of $18.3M, up 42% YoY

## Summary
- Full-year 2023 revenue $18.3M (FY22: $12.9M); sold 151 EksoHealth units.
- Q4 2023 revenue $4.8M (+36% YoY); gross margin 49% vs 47%.
- Net loss FY23 $15.2M ($1.10/sh) vs $15.1M ($1.16/sh) in FY22.
- Cash at Dec 31, 2023: $8.6M, down from $20.5M; raised $3.9M in Jan 2024 offering.
- CMS deferred payment determination for personal exoskeletons (Ekso Indego Personal).

## SEC filing metadata
- accession: 0001437749-24-006421
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000143774924006421/0001437749-24-006421-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000143774924006421/ekso20240302_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-006421
- JSON: https://secwatch.observer/filing/0001437749-24-006421.json
- Plain text: https://secwatch.observer/filing/0001437749-24-006421.txt

## Key facts
- Earnings Releases
  EKSO BIONICS HOLDINGS, INC. reported financial results for three and twelve months ended December 31, 2023.
  - Period: three and twelve months ended December 31, 2023
  - Result: reported results
  source text: On March 4, 2024 Ekso Bionics Holdings, Inc. (the “Company”) reported its financial results for the three and twelve months ended December 31, 2023. The full text of the press release announcing such results is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000143774924006421/0001437749-24-006421-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.